Wednesday, December 24, 2025 | 12:24 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ICMR selects SRM MCHRC as clinical trial site for Covid-19 vaccine

SRM MCHRC is the only medical institution to be selected from Tamil Nadu for this purpose

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
premium

This is the first indigenous vaccine being developed by India

T E Narasimhan Chennai
SRM Medical College Hospital and Research Centre (SRM MCHRC), Kattankulathur, has been selected by Indian Council for Medical Research (ICMR) as a clinical trial site of the country's first indigenous Covid-19 vaccine (BBV152 COVID Vaccine).

According to a college release, SRM Medical College Hospital and Research Centre is one among the 12 institutions in India to have been chosen by ICMR for undertaking human clinical trials of India's first indigenous vaccine developed by ICMR-National Institute of Virology, Pune. ICMR has partnered with Bharat Biotech International limited, Hyderabad.

SRM MCHRC is also the only medical institution to be selected from Tamil